| General Information | |||
|---|---|---|---|
| Term | Tay-Sachs disease | ID (Ontology) | DOID:3320 (Human Disease) |
| Definition | A GM2 gangliosidosis that is characterized onset in infancy of developmental retardation, followed by paralysis, dementia and blindness, with death in the second or third year of life and has_material_basis_in homozygous or compound heterozygous mutation in the alpha subunit of the hexosaminidase A gene (HEXA) on chromosome 15q23. | ||
| Also Known As | "GM2 gangliosidosis, type 1" ; "hexosaminidase A deficiency" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
gangliosidosis |__GM2 gangliosidosis |__Tay-Sachs disease 3 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | GM2 gangliosidosis | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:7737 ICD10CM:E75.02 MESH:D013661 MIM:272800 NCI:C85184 SNOMEDCT_US_2023_03_01:111385000 UMLS_CUI:C0039373 |
|||